Bamco Inc. NY Lowers Stake in Thermo Fisher Scientific Inc.

Institutional investor reduces holdings in medical research company

Mar. 16, 2026 at 8:19am

Got story updates? Submit your updates here. ›

Bamco Inc. NY, an institutional investor, reduced its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 19.7% during the 3rd quarter, according to a recent SEC filing. The firm now owns 24,712 shares of the medical research company's stock, valued at $11,986,000 as of the filing.

Why it matters

Thermo Fisher Scientific is a major player in the medical research industry, providing scientific instruments, reagents, and services to laboratories worldwide. Changes in institutional ownership of the company's stock can signal shifts in investor sentiment and market trends.

The details

According to the SEC filing, Bamco Inc. NY sold 6,054 shares of Thermo Fisher Scientific during the 3rd quarter, reducing its total holdings to 24,712 shares. The firm cited portfolio rebalancing as the reason for the reduced stake. Thermo Fisher Scientific's stock price has fluctuated in recent months, trading between $385.46 and $643.99 over the past 52 weeks.

  • Bamco Inc. NY reduced its position in Thermo Fisher Scientific during the 3rd quarter of 2026.

The players

Bamco Inc. NY

An institutional investor that has reduced its stake in Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

A global provider of scientific instrumentation, reagents, and services that support research, clinical, and industrial laboratories.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Bamco Inc. NY's stake in Thermo Fisher Scientific is a notable shift in institutional ownership of the medical research company's stock, potentially signaling broader market trends or changes in the firm's investment strategy.